Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.155 USD | +2.75% | -1.27% | -20.51% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | +2.75% | ||
1 week | -1.27% | ||
Current month | -5.08% | ||
1 month | -8.82% | ||
3 months | -13.84% | ||
6 months | -3.06% | ||
Current year | -20.51% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.155 | +2.75% | 662,955 |
24-04-18 | 0.1508 | +3.32% | 806,934 |
24-04-17 | 0.146 | -1.35% | 700,478 |
24-04-16 | 0.148 | +2.07% | 1,479,740 |
24-04-15 | 0.145 | -7.64% | 4,669,367 |
Delayed Quote OTC Markets, April 19, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-20.51% | 150M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- CYDY Stock